HEALTH● LOWAug 13 · Aug 13, 2026, 9:29 PM
Bristol gains accelerated approval of iberdomide for multiple myeloma
Seeking Alpha Tech
Bristol has received accelerated approval for iberdomide, a drug intended for the treatment of multiple myeloma. This development expands treatment options for patients with the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH8m agoProud Kakinada is at the heart of India’s return to making Penicillin, says Andhra HRD Minister Nara LokeshThe HinduHEALTH11m agoKeralam to adopt calendar-based infectious disease prevention strategyThe HinduHEALTH22m agoItaly first in Europe to establish national plan against fentanyl says MeloniANSA [en]HEALTH25m agoMalaria: Nigeria’s prevalence drops to 15.2%, FG targets 50% reduction by 2030Vanguard Nigeria